Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
Study Details
Study Description
Brief Summary
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
PRIMARY OBJECTIVE:
- To evaluate CareConnect's efficacy on referring patients to tobacco cessation resources.
SECONDARY OBJECTIVE:
- To evaluate patients' acceptance of referrals. II. To evaluate the acceptability of CareConnect.
EXPLORATORY OBJECTIVES:
-
In-depth semi-structured qualitative interviews of 20 randomly selected participants who completed the 3-month follow-up call (10 from each group).
-
Smoking cessation with biochemical verification.
OUTLINE:
Eligible participants, identified through the Cancer Center Tobacco Registry will be randomized to either the Intervention or Control arm on a 1:1 ratio. Participants who complete the first call of CareConnect or AutoReach will be considered enrolled. Participants will complete a baseline assessment, a 3-month assessment, and have biological samples taken (saliva and breath).
For those who are selected to participate in an in-depth interview , this will take place within 1 month after the 3-month assessment. Data from the participants medical record may be accessed at 6 months post follow-up.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: CareConnect (Intervention) Participants will receive automated 'CareConnect' calls/SMS text at enrollment. The call protocol will include up to 2 calls on 2 consecutive days if no response to the first call. If there is no response to call, a follow up SMS 3-4 days later. Each CareConnect contact will include (1) assessment, (2) motivational enhancement tailored to participants' tobacco use status and importance of quitting; and (3) multiple referral options (UCSF Fontana Tobacco Treatment Center (FTTC)/tobacco treatment specialist, Quitline, or smokefreeTXT from smokefree.gov), offered after the motivational enhancement message. CareConnect will notify the UCSF tobacco treatment specialist of participants acceptance of any of the referral options. Referral options will be documented by the specialist on the participants electronic health record (EHR). All participants who have completed the CareConnect call will be contacted by research staff for a 3-month survey to be completed online or by telephone. |
Behavioral: CareConnect
A combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR)
Other Names:
Procedure: Biospecimen samples
Saliva and breath sample
Other Names:
|
| Other: AutoReach (Control) Participants will receive automated AutoReach calls/Short Message Service (SMS) text at enrollment provides one referral option (speaking with a tobacco treatment specialist) and an option for sending information on cessation resources. All participants who have completed the AutoReach call will be contacted by research staff for a 3-month survey to be completed online or by telephone. |
Other: AutoReach
Phone call / SMS Text
Other Names:
Procedure: Biospecimen samples
Saliva and breath sample
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Proportion of participants who report using any smoking cessation resources [Up to 3 months]
Self-reported receipts (recorded as 'yes' or 'no') of evidence-based, smoking cessation services assessed at 3 months post-intervention will be reported as a proportion.
Secondary Outcome Measures
- Proportion of participants who started the call and chose the referrals [Up to 3 months]
Proportion of participants who started the call and chose the referrals to quitline/speaking with a tobacco treatment specialist or to use smokefree.gov
- Mean Satisfaction Ratings (CareConnect Group Only) [Up to 3 months]
Participants in the CareConnect intervention group will be asked to respond to the following single item to measure overall satisfaction with the CareConnect intervention from answers to the following question "How helpful was the call you received about tobacco use and cancer care?". The response to this single item is scored on a range from 0= 'Not at all helpful' to 4= 'Extremely helpful'. Higher scores indicate a greater degree of satisfaction.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 18 years and older.
-
Able to understand study procedures and to comply with them for the entire length of the study.
-
Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
-
English, Spanish, Cantonese, or Mandarin speaking.
-
Self-reported current use of tobacco, including e-cigarette on EHR.
-
Has a diagnosis of cancer.
-
Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months.
Exclusion Criteria:
-
Contraindication to any study-related procedure or assessment.
-
No valid contact telephone number.
-
Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of California, San Francisco | San Francisco | California | United States | 94143 |
Sponsors and Collaborators
- University of California, San Francisco
- Tobacco Related Disease Research Program
Investigators
- Principal Investigator: Janice Tsoh, PhD, University of California, San Francisco
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 226310
- NCI-2023-03215